<DOC>
	<DOC>NCT02548195</DOC>
	<brief_summary>To evaluate of adjuvant therapy using oxaliplatin and gemcitabine (GEMOX regimen) versus capecitabine alone chemotherapy in patients who underwent curative surgery for intrahepatic cholangiocarcinoma (ICC) -- a randomized control study.</brief_summary>
	<brief_title>Oxaliplatin+Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma</brief_title>
	<detailed_description>chemotherapy: GEMOX vs capecitabine alone; adjuvant settings; primary endpoint: recurrence-free survival (RFS); second endpoint: overall survival after surgery (OS).</detailed_description>
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>ECOG PSâ‰¤1; pathologically confirmed adenocarcinoma of bile duct; R1 resection or R0 resection with these risk factors: lymph node metastasis, lymphatic vessel or blood vessel invasion, multiple tumors, tumor size &gt;5 cm, preoperative CA199&gt;200 U/mL. postoperative liver function Child Pugh Class A, leukocyte count&gt;1.5*10^9/L, platelet count&gt;100*10^9/L, serum alanine aminotransferase &lt;1.5*ULN no tumor recurrence or metastasis on baseline examination no history of radiotherapy or intervention therapy hepatocellular carcinoma, mixed carcinoma of ICC and HCC, or hilar cholangiocarcinoma distant metastasis prothrombin time &gt;14s severe cardiopulmonary dysfunction severe renal dysfunction bone marrow suppression before the initiation of therapy allergic to fluorouracil, gemcitabine, or platinum gemcitabine was used in combination with radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>GEMOX</keyword>
	<keyword>intrahepatic cholangiocarcinoma</keyword>
	<keyword>adjuvant therapy</keyword>
	<keyword>oxaliplatin</keyword>
	<keyword>gemcitabine</keyword>
	<keyword>capecitabine</keyword>
	<keyword>curative surgery</keyword>
</DOC>